In order to provide equal access and equal opportunity to people with diverse abilities, this site has been designed with accessibility in mind. Click here to view
OKLAHOMA CITY— Senator Brenda Stanley, R-Midwest City, announced Senate Bill 933, known as the Right to Try for Individualized Treatments Act, has been signed into law. The measure expands access to individualized investigational treatments for eligible patients in Oklahoma.
The new law allows eligible patients to request individualized investigational treatments from facilities authorized to provide them, offering additional options for individuals facing serious medical conditions.
“This legislation is about giving hope to patients and families who may have exhausted all traditional treatment options,” Stanley said. “Oklahomans deserve the opportunity to pursue innovative, individualized care in consultation with their doctors, without unnecessary red tape.”
The measure does not require health plans, third-party administrators, governmental agencies, hospitals, or medical facilities to provide or pay for individualized investigational treatments. However, insurers and governmental agencies may choose to provide coverage for such treatments. The law also does not expand mandatory health care coverage requirements related to clinical trial participation.
SB 933 includes liability protections for treatment manufacturers and health care providers acting in good faith while complying with the law. It also protects licensed health care providers from disciplinary action solely for recommending individualized investigational treatments to eligible patients. Similar protections apply regarding Medicare certifications.
The legislation further provides that if a patient passes away while receiving an individualized investigational treatment, the patient’s heirs are not liable for outstanding debt related to that treatment.
“Patients facing difficult diagnoses should have every possible opportunity to pursue promising treatment options,” Stanley added. “This law helps ensure Oklahoma supports medical freedom, innovation, and compassionate care.”
The provisions of SB 933 will become effective Nov. 1.
###
For more information, contact: communications@oksenate.gov.